| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 1642112-32-0 | AMG8380 |
≥98% | | 询价 |
| 2 | 2308496-47-9 | Pip-alkyne-Ph-COOCH3 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 3 | | m-PEG13-Boc |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 4 | 2280998-74-3 | m-PEG11-acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 5 | 106983-27-1 | N-(3-Oxooctanoyl)-DL-homoserine lactone |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 6 | 1085938-09-5 | Biotin-PEG6-azide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 7 | 1625677-63-5 | EGFR-IN-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 8 | | EGFR-IN-1 TFA |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 9 | 2227455-78-7 | EGFR-IN-1 HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 10 | | Balixafortide TFA |
≥98% | | 询价 |
| 11 | 115819-92-6 | N-Hydroxypipecolic acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 12 | 52334-92-6 | 2-(Dimethylamino)acetaldehyde |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 13 | 2170209-52-4 | PD-1/PD-L1-IN 5 TFA |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 14 | 152657-84-6 | Nalfurafine(TRK 820,AC 820,MT 9938) |
≥98% | | 询价 |
| 15 | 23313-12-4 | L-Ascorbic acid 2-phosphate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 16 | 286930-02-7 | Fesoterodine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 17 | 3469-78-1 | AMP-PCP |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 18 | 1228439-36-8 | KCC2 blocker 1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 19 | 1853164-83-6 | IPN-60090(IACS-6274) |
≥98% | | 询价 |
| 20 | 1220751-16-5 | TAT-DEF-Elk-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 21 | 1268955-50-5 | TXNIP-IN-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 22 | 101526-83-4 | Sematilide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 23 | 73604-30-5 | (-)-Bicuculline methobromide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 24 | | Omiganan-FITC |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 25 | 89-65-6 | Erythorbic acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 26 | 122-57-6 | Benzylideneacetone |
≥98% | | 询价 |
| 27 | 57601-68-0 | Selenalysine |
≥98% | | 询价 |
| 28 | 70384-91-7 | Lortalamine |
≥98% | | 询价 |
| 29 | 857066-90-1 | TMC353121 |
≥98% | | 询价 |
| 30 | 872178-65-9 | Rabeximod |
≥98% | | 询价 |
| 31 | 73196-97-1 | Dactimicin |
≥98% | | 询价 |
| 32 | 151227-58-6 | AP-521(Free base) |
≥98% | | 询价 |
| 33 | 1883803-09-5 | sEH-IN-12 |
≥98% | | 询价 |
| 34 | 26000-17-9 | Lycoctonine |
≥98% | | 询价 |
| 35 | 1020201-82-4 | BH-IAA |
≥98% | | 询价 |
| 36 | 195615-83-9 | Blarcamesine |
≥98% | | 询价 |
| 37 | 1425973-16-5 | Azido-PEG5-acid |
≥98% | | 询价 |
| 38 | 133585-55-4 | Sandoricin |
≥98% | | 询价 |
| 39 | 2150-48-3 | Pyronine B |
≥98% | | 询价 |
| 40 | 351351-75-2 | Braco-19 |
≥98% | | 询价 |
| 41 | 167467-53-0 | BMS-186511 |
≥98% | | 询价 |
| 42 | 29621-88-3 | Selenocystine,L- |
≥98% | | 询价 |
| 43 | 300347-11-9 | AH-1058 free base |
≥98% | | 询价 |
| 44 | 1270138-41-4 | NSI-189 Phosphate |
≥98% | | 询价 |
| 45 | | Broxuridine sodium |
≥98% | | 询价 |
| 46 | 120555-31-9 | Ro 24-0238 |
≥98% | | 询价 |
| 47 | 4317-14-0 | Amitriptylinoxide |
≥98% | | 询价 |
| 48 | 57998-68-2 | Diaziquone |
≥98% | | 询价 |
| 49 | 7795-58-6 | Palmitoyllactic acid |
≥98% | | 询价 |
| 50 | 1057249-41-8 | SNS-314 |
≥98% | | 询价 |
| 51 | 2226521-65-7 | FM-381 |
≥98% | | 询价 |
| 52 | 2140301-97-7 | PF-06651600(Ritlecitinib)malonate |
≥98% | | 询价 |
| 53 | 1792180-81-4 | Ritlecitinib(PF-06651600) |
≥98% | | 询价 |
| 54 | 1467057-23-3 | PF-06409577 |
≥98% | | 询价 |
| 55 | 1425043-73-7 | IPI-3063 |
≥98% | | 询价 |
| 56 | 1195768-06-9 | Dabrafenib Mesylate |
| 5mg, 10mg, 50mg, 100mg | 询价 |
| 57 | 1639417-54-1 | Tenalisib R Enantiomer |
≥98% | | 询价 |
| 58 | 1639417-53-0 | Tenalisib |
≥98% | | 询价 |
| 59 | 464930-42-5 | SSR-240612 HCl |
≥98% | | 询价 |
| 60 | 1846570-31-7 | CM-272 |
≥98% | | 询价 |
m.cnreagent.com